The Australian Medical Association Limited and state AMA entities comply with the Privacy Act 1988. Please refer to the AMA Privacy Policy to understand our commitment to you and information on how we store and protect your data.

×

Search

×

PBAC nominations invited

04 Mar 2014

AMA members are invited to nominate for a specialist position on the Pharmaceutical Benefits Advisory Committee (PBAC).

This is a challenging and stimulating position that provides the opportunity to contribute directly to pharmaceutical benefits policy in Australia.

PBAC is an independent expert committee that advises the Minister for Health on medicines in relation to the Pharmaceutical Benefits Scheme.

PBAC is required to consider the clinical effectiveness, safety and cost effectiveness of a medication compared with existing therapies. Members must be able to interpret the comparative outcomes of therapy involving a medicine, and appraise evidence.

The AMA has been asked to nominate candidates with expertise in infectious diseases/microbiology and paediatrics.

The AMA’s Federal Executive Council will assess nominations prior to forwarding them to the Minister for potential appointment.

PBAC meets for three, three-day meetings a year, and may occasionally hold additional one-day meetings. PBAC members currently receive an annual salary of $36,750, and all travel costs are reimbursed. Appointments are for four years.

Further information about PBAC can be found on the Department of Health website at www.health.gov.au.

To nominate, please forward a curriculum vitae, including your contact details, that is no longer than 2 pages (Click here for an example) to cmoylan@ama.com.au by Wednesday, 5 March 2014. If you have any questions, please contact Georgia Morris on 02 6270 5466.


Published: 04 Mar 2014